Patents Assigned to American Health Foundation
-
Publication number: 20030096863Abstract: A method is provided for inhibiting the development of colon tumorigenesis in a mammal by administering to the mammal a pharmacologically effective amount of an isothiocyanate selected from the group consisting of sulforaphane and phenethyl isothiocyanate.Type: ApplicationFiled: July 15, 2002Publication date: May 22, 2003Applicant: AMERICAN HEALTH FOUNDATIONInventors: Fung-Lung Chung, Bandaru Reddy, C. Clifford Conaway
-
Patent number: 6433011Abstract: A method is provided for inhibiting the development of colon tumorigenesis in a mammal by administering to the mammal a pharmacologically effective amount of an isothiocyanate selected from the group consisting of sulforaphane and phenethyl isothiocyanate.Type: GrantFiled: March 8, 2000Date of Patent: August 13, 2002Assignee: American Health FoundationInventors: Fung-Lung Chung, Bandaru Reddy, C. Clifford Conaway
-
Patent number: 5741678Abstract: There is disclosed a quantitative sensitive method to enable the detection of point mutations at a known site to a diagnostic kit which uses a multi step (for example, four steps) or a single step reaction. The method uses selective polymerase chain reaction (PCR) amplification of mutant test gene sequences involving first stage amplification of both mutant and wild-type sequences, first stage restriction enzyme digestion of only wild-type sequences, second stage amplification of undigested amplified fragments enriched in mutant sequences and second stage digestion of previously undigested wild-type sequences. Long and short tail primers are used in the first and second stages of amplification respectively to enable selective amplification (in the second stage) of only previously amplified material and none of the original test genomic DNA.Type: GrantFiled: July 23, 1996Date of Patent: April 21, 1998Assignee: American Health FoundationInventor: Zeev A. Ronai
-
Patent number: 5626738Abstract: A method for detecting a nitrosothiol in an eluant from a chromatographic process including passing the eluant through a series of electrodes comprising an upstream working electrode and a downstream working electrode. The upstream working electrode is maintained at a potential adequate to reduce the nitrosothiol to a corresponding thiol. The downstream electrode is maintained at a potential to detect the corresponding thiol.Type: GrantFiled: November 17, 1995Date of Patent: May 6, 1997Assignee: American Health FoundationInventor: John P. Richie
-
Patent number: 5512441Abstract: There is disclosed a quantitative sensitive method to enable the detection of point mutations at a known site to a diagnostic kit which uses a multi step (for example, four steps) or a single step reaction. The method uses selective polymerase chain reaction (PCR) amplification of mutant test gene sequences involving first stage amplification of both mutant and wild-type sequences, first stage restriction enzyme digestion of only wild-type sequences, second stage amplification of undigested amplified fragments enriched in mutant sequences and second stage digestion of previously undigested wild-type sequences. Long and short tail primers are used in the first and second stages of amplification respectively to enable selective amplification (in the second stage) of only previously amplified material and none of the original test genomic DNA.Type: GrantFiled: November 15, 1994Date of Patent: April 30, 1996Assignee: American Health FoundationInventor: Zeey A. Ronai
-
Patent number: 5391568Abstract: A method is provided for reducing the incidence of lung cancer in a mammal by administering thereto a pharmacologically effective amount of epigallocatechin gallate (EGCG). The EGCG may be administered to the mammal in the form of drinking water and particularly in the form of, for example, 2% green tea. The EGCG may be isolated prior to administering the same and is subsequently put into solution for administration thereof. The EGCG is an antioxidant.Type: GrantFiled: July 10, 1992Date of Patent: February 21, 1995Assignee: American Health FoundationInventor: Fung L. Chung
-
Patent number: 5260283Abstract: Wheat bran fiber is used to alter the enterohepatic recirculation of estrogens leading to an increased fecal excretion of estrogens together with a decrease in urinary excretion of estrogens. Increased lipid excretion is also found. Thus wheat bran fiber is useful to remove estrogen and lipid in mammals.Type: GrantFiled: May 19, 1992Date of Patent: November 9, 1993Assignee: American Health FoundationInventors: Marcia E. Kendall, Leonard A. Cohen
-
Patent number: 5231209Abstract: A method of inhibiting lung tumor multiplicity and/or incidence by treating mammals with relatively long chain arylalkyl isothiocyanates, especially effective with respect to tumors induced by exposure to tobacco-specific nitrosamine. Among the isothiocyanates are 4-phenylbutyl isothiocyanate, phenylpentyl isothiocyanate and phenylhexyl isothiocyanate, which are synthesized by adding hydrochloride of phenylbutylamine, phenylpentylamine, or phenylhexylamine in water to thiophosgene in an inert organic solvent. For comparison testing, oxo-pyridyl butyl isothiocyanate is synthesized by dissolving myosmine in HCl to obtain a hydrochloride salt, suspending the salt in dry chloroform, adding thiophosgene, and adding chloroform containing triethylamine.Type: GrantFiled: December 13, 1991Date of Patent: July 27, 1993Assignee: American Health FoundationInventors: Fung-Lung Chung, Stephen S. Hecht, Karin Eklind, Mark A. Morse
-
Patent number: 5114969Abstract: A method of inhibiting lung tumor multiplicity and/or incidence by treating mammals with relatively long chain arylalkyl isothiocyanates, especially effective with respect to tumors induced by exposure to tobacco-specific nitrosamine. Among the isothiocyanates are 4-phenylbutyl isothiocyanate, phenylpentyl isothiocyanate and phenylhexyl isothiocyanate, which are synthesized by adding hydrochloride of phenylbutylamine, phenylpentylamine, or phenylhexylamine in water to thiophosgene in an inert organic solvent. For comparison testing, oxo-pyridyl butyl isothiocyanate is synthesized by dissolving myosmine in HCl to obtain a hydrochloride salt, suspending the salt in dry chloroform, adding thiophosgene, and adding chloroform containing triethylamine.Type: GrantFiled: May 31, 1990Date of Patent: May 19, 1992Assignee: American Health FoundationInventors: Fung-Lung Chung, Stephen S. Hecht, Karin Eklind, Mark A. Morse
-
Patent number: 5011697Abstract: L-Tryptophan is applied to foodstuff to prevent the development of mutagens/carcinogens. Before the cooking of a foodstuff such as hamburger, L-Tryptophan is applied to the surfaces thereof to inhibit, for example, the generation of IQ type carcinogens. The L-Tryptophan can be sprinkled on the surface of the foodstuff or incorporated into a sauce which is applied to the foodstuff or put into solution in water or the like.Other non-toxic indoles such as L-proline have identical properties in specifically blocking the formation of heterocyclic amino type mutagens and carcinogens, as do mixtures of L-tryptophan and L-proline.Type: GrantFiled: August 6, 1988Date of Patent: April 30, 1991Assignee: American Health FoundationInventors: Ronald C. Jones, John H. Weisburger
-
Patent number: 4988517Abstract: It is shown that benzylselenocyanate in the diet significantly inhibits the incidence (percentage of animals with tumors) and multiplicity (number of tumors per animal) of adenocarcinomas in the colon and multiplicity of adenocarcinomas in the small intestine compared to those fed a control diet. Selenium-dependant glutathione peroxidase activity is significantly increased in kidneys and colon and small intestinal mucosae of animals fed a benzylselenocyanate diet compared to animals fed control diets. BSC in the diet is a superior inhibitor to both its sulfur analog BTC and the inorganic selenium (sodium selenite) during the initiation phase of carcinogenesis.Type: GrantFiled: September 27, 1988Date of Patent: January 29, 1991Assignee: American Health FoundationInventors: Karam El-Bayoumy, Bandaru S. Reddy
-
Patent number: 4923813Abstract: Monoclonal antibodies specific for the 8R,6R- and 8S,6S-stereoisomers of 3-(2-deoxy-.beta.-D-erythropentofuransyl)-5,6,7,8-tetrahydro-8-hydroxy-6-m ethylpyrimido[1,2-a]purine-10(3H)one were produced. These cyclic 1,N.sup.2 -propanodeoxyguanosines are formed in DNA exposed to crotonaldehyde in vitro. Three of the four antibodies were most specific for one stereoisomer while the fourth was most specific for the other stereoisomer. Fifty % inhibition of binding in an enzyme-linked immunoabsorbent assay could be achieved with 0.2 picomol of either stereoisomer. A high-pressure liquid chromatography-enzyme-linked immunoabsorbent assay using two of these antibodies and capable of detecting 0.5 .mu.mol of 1,N.sup.2 -propanodeoxyguanosine per mol of deoxyguanosine was developed. The method was validated by comparison to results obtained with fluorescence assay.Type: GrantFiled: January 15, 1988Date of Patent: May 8, 1990Assignee: American Health FoundationInventors: Stephen S. Hecht, Peter G. Foiles, Fung-Lung Chung
-
Patent number: 4777052Abstract: L-Tryptophan is applied to foodstuff to prevent the development of mutagens/carcinogens. Before the cooking of a foodstuff such as hamburger, L-Tryptophan is applied to the surfaces thereof to inhibit, for example, the generation of IQ type carcinogens. The L-Tryptophan can be sprinkled on the surface of the foodstuff or incorporated into a sauce which is applied to the foodstuff or put into solution in water or the like.Type: GrantFiled: January 6, 1987Date of Patent: October 11, 1988Assignee: American Health FoundationInventors: John Weisburger, Ronald C. Jones